2023 Advanced Heart Failure Symposium

Initial Evaluation of a NIDCM PT and the Work Up

Objectives

• The participant will be able to list 3 questions that are pertinent to use when assessing heart failure symptoms
• The participant will describe the proper way to assess JVD and HJR to assess volume status in a heart failure patient
• The participant will be able to list symptoms that would lead them to think the patient may be in a low output state.

Advanced Ambulatory and Inpatient Pharmacologic Therapies

Objectives

• Describe appropriate strategies to optimize use of current and novel drug therapy in patients with advanced heart failure
• Review how to manage congestion in patients with advanced HF

Recognizing Advanced HF/ When to refer

Objectives

• The nurse will be able to use both objective and subjective data when assessing their patient, to help figure out when someone should be referred to an Adv HF program.
• They will know what testing to order to help determine this state and be able to interpret the results.

Recognizing CS

Objectives

• The participant will be able to name 3 signs of cardiogenic shock
• The participant will identify the categories of Cardiogenic Shock
• The participant will understand the temporary devices used to care for the patient in cardiogenic shock

Hypertrophic CM

Objectives

• Review how to diagnose Hypertrophic Cardiomyopathy including non-obstructive and obstructive
• Describe current pharmacological, non-pharmacological and lifestyle modifications, for HCM
• Discuss the current role of genetic testing in HCM

Advanced Hemodynamics with case studies; PCW SVR, etc. Beyond PAP

Objectives

• The participants will be able to discern the primary driver of abnormal hemodynamics with in the cardio-pulmonary system.
• The participants will be able to name the pertinent hemodynamic variables to determine pulmonary arterial hypertension from pulmonary venous hypertension.

Advanced Hemodynamics in the Postoperative CTICU Patient (post VAD post-transplant)

Objectives

• The participant will be able to identify target hemodynamics for patients who are: post durable LVAD implant post heart transplantation supported by tMCS
• The participant will identify interventions in response to abnormal hemodynamics in post-transplant and post LVAD patients.
• The participant will learn escalation and de-escalation of support based on CPO, PAPI , and clinical course of the patient.

Peripartum CM with Cases

Objectives

• Learn results of the PPCM PCN trial results
• Learn what the latest guidelines say about managing PPCM
• Review difficult cases that will help with understanding multidisciplinary management of PPCM

Cardio-Renal Syndrome

Objectives

• The participant will be able to describe the strategies used in decongesting a patient with decompensated heart failure and chronic kidney disease.
• The participant will be able to describe the interaction between hypervolemia and renal perfusion/function

scPharmaceuticals FUROSCIX® Supported Commercial

Genetic CM and the Benefit of genetic counseling

Objectives

• The participant will understand the role of the genetic counselor, in the care of the genetic cardiomyopathy patient
• After hearing the signs and symptoms of the most prevalent genetic cardiomyopathies, the participant will increase their screening of DCM patients for genetic causes
• Once someone is diagnosed with a genetic cardiomyopathy, the participant will understand the symptoms that they are at risk for and implement the necessary preventative measures

Contractility Modulation Broaden to other modulating/remodeling devices

Objectives

• To understand the target population for CCM, and the principles of therapy
• To provide insight into the path from patient identification to device implant

Temporary Assist Devices Temporary MCS Complications

Objectives

• The participant will be able to describe the indications for temporary devices
• The participant will be able to understand the determinants in choosing specific temporary devices.

Infiltrative: Amyloid Sarcoid Myocarditis

Objectives

• The participant will understand the Red Flag symptoms for an infiltrative cardiomyopathy
• The participant will know the therapies used to treat infiltrative cardiomyopathies and if unable to initiate them, will refer the patients to an Infiltrative CM program

Structural Heart: TAVR MitraClip Investigational Percutaneous Devices

Objectives

• The participant will be able to identify the appropriate candidate for Mitral Clip, TAVR or Tricuspid clip, along with the studies involved in making the decision.
• The participant will recognize the care needed following a structural heart procedure.